3-nitropropionic acid has been researched along with Memory Disorders in 5 studies
3-nitropropionic acid: succinate dehydrogenase inactivator; biosynthesized by FABACEAE plants from ASPARAGINE
3-nitropropanoic acid : A C-nitro compound that is propanoic acid in which one of the methyl hydrogens has been replaced by a nitro group.
Memory Disorders: Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pretreatment with genistein and 17β-estradiol attenuated locomotor hypoactivity, increased retention latencies in the passive avoidance task, increased ATP levels, improved the oxidative stress profile, attenuated the increase in AChE activity and decreased the expression of COX-2 and iNOS." | 1.42 | Genistein improves 3-NPA-induced memory impairment in ovariectomized rats: impact of its antioxidant, anti-inflammatory and acetylcholinesterase modulatory properties. ( Abdel-Naim, AB; Esmat, A; Khalifa, AE; Menze, ET; Tadros, MG, 2015) |
| "Treatment with moxonidine, NDDCT and TBZ significantly attenuated 3-NPA induced reduction in body weight, locomotor activity, grip strength, anxiety as well as impaired learning and memory." | 1.40 | Pharmacological benefit of I(1)-imidazoline receptors activation and nuclear factor kappa-B (NF-κB) modulation in experimental Huntington's disease. ( Gupta, S; Sharma, B, 2014) |
| "Huntington's disease is an incurable, adult-onset, dominantly inherited neurodegenerative disease." | 1.35 | Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats. ( Akula, KK; Dhir, A; Kulkarni, SK, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, S | 1 |
| Sharma, B | 1 |
| Menze, ET | 1 |
| Esmat, A | 1 |
| Tadros, MG | 1 |
| Abdel-Naim, AB | 1 |
| Khalifa, AE | 1 |
| Suganya, SN | 1 |
| Sumathi, T | 1 |
| Li, XM | 1 |
| Zhu, BG | 1 |
| Ni, JB | 1 |
| Cao, CY | 1 |
| Zhang, JP | 1 |
| Zhao, XD | 1 |
| Zhu, RS | 1 |
| Dhir, A | 1 |
| Akula, KK | 1 |
| Kulkarni, SK | 1 |
5 other studies available for 3-nitropropionic acid and Memory Disorders
| Article | Year |
|---|---|
Pharmacological benefit of I(1)-imidazoline receptors activation and nuclear factor kappa-B (NF-κB) modulation in experimental Huntington's disease.
Topics: Adrenergic Uptake Inhibitors; Animals; Anxiety; Brain; Disease Models, Animal; Ditiocarb; Huntington | 2014 |
Genistein improves 3-NPA-induced memory impairment in ovariectomized rats: impact of its antioxidant, anti-inflammatory and acetylcholinesterase modulatory properties.
Topics: Acetylcholinesterase; Animals; Antioxidants; Behavior, Animal; Biomarkers; Catalase; Corpus Striatum | 2015 |
Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.
Topics: Acetylcholinesterase; Animals; Antioxidants; Body Weight; Corpus Striatum; Glial Fibrillary Acidic P | 2017 |
No spatial memory deficit exists in Kunming mice that recently recovered from motor defects following 3-nitropropionic acid intoxication.
Topics: Animals; Behavior, Animal; Convulsants; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred St | 2009 |
Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
Topics: Animals; Behavior, Animal; Brain Chemistry; Disease Models, Animal; Dose-Response Relationship, Drug | 2008 |